{"retracted":false,"update":{"timestamp":1380326400000,"doi":"10.1016/j.canlet.2013.03.033","type":"err"},"doi":"10.1016/j.canlet.2013.01.022","journal":"Cancer Letters","publisher":"Elsevier BV","title":"Corrigendum to ‘A novel antitumor activity of deguelin targeting the insulin-like growth factor (IGF) receptor pathway via up-regulation of IGF-binding protein-3 expression in breast cancer’ [Cancer Lett. 332/1 (2013) 102–109]"}
